Stavudine
Links shared publicly online about this topic
Infectious Disease News & Articles - MDLinx - Stavudine on #MDlinx
mdlinx.com — “Infectious Disease News & Articles - MDLinx - Stavudine on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 22, 2010 at 10:02 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A Chewable Pediatric Fixed-dose Combination Tablet of Stavudine, Lamivudine, and Nevirapine: Pharmacokinetics a... http://bit.ly/aQ0s5V #ID
Anxiety (Stress and anxiety) in Stavudine - eHealthMe.com
ehealthme.com — “Real world drug outcomes: 13 people have Anxiety when using Stavudine” View full resource at ehealthme.com
Most Recently Shared on May 28, 2010 at 3:12 am By:
Peter H Brown Doctor and Psychologist
AnxietyStress and anxiety in Stavudine eHealthMecom http://bit.ly/bNIxTf #anxiety #stress
Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology
hindawi.com — “The aim of the current study was to formulate and optimize the formulation on the basis of in vitro performance of microsphere. A full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio () and stirring speed (), on dependent variables, encapsulation efficiency, particle size, and time to 80% drug release. The best batch exhibited a high entrapment efficiency of 70% and mean particle size 290??m. The drug release was also sustained for more than 12 h” View full resource at hindawi.com
Most Recently Shared on June 28, 2011 at 9:17 pm By:
Urology & Nephrology OW Health
Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology: The... http://bit.ly/lE7OYO
European Medicines Agency Issues Restricted Indication for d4T (Stavudine) - The Body
thebody.com — “The European Medicines Agency has completed a review of Zerit as part of the procedure for the renewal of the medicine's marketing authorisation.” View full resource at thebody.com
Most Recently Shared on May 26, 2011 at 12:00 pm By:
European Medicines Agency Issues Restricted Indication for d4T (Stavudine) http://bit.ly/io5OLR #hiv #aids
WHO wants common AIDS drug phased out - AIDS- msnbc.com
msnbc.msn.com — “Countries should phase out the use of stavudine, the most common AIDS drug, because of "long-term, irreversible" side effects, the World Health Organization said on Monday.” View full resource at msnbc.msn.com
Most Recently Shared on November 30, 2009 at 7:26 pm By:
msnbc.com - Health Health News
WHO wants common AIDS drug phased out http://bit.ly/5yhqmy
Full-dose nevirapine may lead to rash in children with HIV
pediatricsupersite.com — “A full-dose regimen of stavudine, lamivudine and nevirapine was linked to high rates of rash but only a 12% rate of clinical toxicity, according to” View full resource at pediatricsupersite.com
Most Recently Shared on October 13, 2010 at 2:23 pm By:
Pediatric SuperSite Health Site
Full-dose #nevirapine may lead to rash in children with 3HIV: http://ow.ly/2SQNk
Drug Safety Update Volume 4, Issue 9, April 2011 : MHRA
mhra.gov.uk — “Drug Safety Update Volume 4, Issue 9, April 2011 : MHRA” View full resource at mhra.gov.uk
Most Recently Shared on March 4, 2011 at 2:30 pm By:
April issue of MHRA's Drug Safety Update includes advice on stavudine, tigecycline and atypical antipsychotics: http://bit.ly/eUG9Ff
New WHO guidelines urge phase-out of major HIV drug | Reuters
feeds.reuters.com — “GENEVA (Reuters) - Countries should phase out the use of stavudine, the most common AIDS drug, because of long-term, irreversible side effects in HIV patients including wasting and a nerve disorder, the” View full resource at feeds.reuters.com
Most Recently Shared on November 30, 2009 at 12:39 am By:
New WHO guidelines urge phase-out of major HIV drug http://link.reuters.com/gyj93g
Also in global health news: Kenya HIV/AIDS; Uganda bill; water project in Philippines; U.N. appeal for Yemen
news-medical.net — “U.S. Ambassador Michael Ranneberger on Wednesday announced the U.S. would provide $26.5 million (2.7 billion Kenyan shillings) between 2009 and 2013 to fight HIV/AIDS in Kenya, the Daily Nation reports (Sinundu, 12/16). In related news, the Standard reports the Kenyan government will be begin the gradual phase out of the antiretroviral drug, Stavudine, which is known to cause adverse side effects (Mwai, 12/15).” View full resource at news-medical.net
Most Recently Shared on December 17, 2009 at 10:00 am By:
HIV/AIDS News: Also in global health news: Kenya HIV/AIDS; Uganda bill; water project in Philippines; U.N. appeal f... http://bit.ly/5BJnor
Forum on Managing Side Effects of HIV Treatment: what causes muscle and fat loss
thebody.com — “Fat loss in HIV can be due to age, history of low CD4 count, genetics, certain HIV meds (ie stavudine and zidovudine), and other factors. If she is taking stavudine or zivodudine should check to...” View full resource at thebody.com
Most Recently Shared on April 14, 2011 at 2:01 pm By:
Ask the HIV/AIDS Experts: "Why Is My Sister Losing Fat and Muscle?" http://bit.ly/gCtKSJ #wasting #lipoatrophy
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
